Skip to main content
Midas Edge

JUPITER NEUROSCIENCES, INC.

For the period ended Jun 30, 2026. Filed Aug 14, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 14, 2026

JUNS$2.200.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 6. Exhibits

Exhibit No.Description
1.1Form of Placement Agent Agreement, dated May 20, 2026, by and between the Company and D. Boral Capital LLC (incorporated by reference to Exhibit 1.1 of the Company’s Current Report on Form 8-K filed with the SEC on May 21, 2026).
3.1Certificate of Amendment to the Certificate of Incorporation of Jupiter Neurosciences, Inc (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K filed with the SEC on August 6, 2026).
10.1Form of Securities Purchase Agreement, dated as of May 20, 2026, by and between Jupiter Neurosciences, Inc. and the purchaser parties thereto (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on May 21, 2026).
10.2+Amendment No. 3 to Executive Employment Agreement, dated as of June 5, 2026, between the Company and Alison Silva (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on June 5, 2026).
10.3†Strategic Asset License Agreement, dated as of July 20, 2026, by and between PharmAla Biotech Holdings Inc. and Jupiter Neurosciences, Inc. (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on July 21, 2026).
31.1*Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act*
31.2*Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act*
32.1*Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act**
32.2*Certification of Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act**
101.INS*Inline XBRL Instance Document*
101.SCH*Inline XBRL Taxonomy Extension Schema Document*
101.CAL*Inline XBRL Taxonomy Extension Calculation Linkbase Document*
101.DEF*Inline XBRL Taxonomy Extension Definition Linkbase Document*
101.LAB*Inline XBRL Taxonomy Extension Label Linkbase Document*
101.PRE*Inline XBRL Taxonomy Extension Presentation Linkbase Document*
104*Cover Page Interactive Data File (embedded within the Inline XBRL document)*
  • Filed herewith.

** Furnished herewith.

  • Indicates a management contract or compensation plan or arrangement.

† Certain portions of this exhibit (indicated by “[***]”) have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K because the omitted information is not material and is the type of information that the registrant customarily and actually treats as private or confidential.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.